News Room

Raybow was founded in 2008 as the CDMO division of Jiuzhou Pharmaceutical to provide expert process development and manufacturing for biotech and large pharma clients. Raybow can accommodate a variety of chemistries, including high potency, and offers high quality, efficient and cost-effective services designed to accelerate the drug development process. Raybow manufactures advanced intermediates, regulatory starting materials and active pharmaceutical ingredients in US FDA inspected facilities in Taizhou and Suzhou China and Brevard, NC in the United States. PR&D facilities are located in Hangzhou and Taizhou in China and Brevard, North Carolina in the U.S. Client projects cover all phases of development from pre-clinical to commercial.

Raybow News & Papers

Privileged Chiral Spiro Ligands and Applications to Commercially Marketed APIs

Privileged Chiral Spiro Ligands and Applications to Commercially Marketed APIs

Raybow PharmaScience attending Chemoutsourcing in Parsippany, New Jersey

Raybow is attending Chemoutsourcing in Parsippany, New Jersey September 7th-9th.

Raybow PharmaScience Attends CPhI Worldwide in Fiera Milano, Milan, Italy

Raybow is attending CPhI Worldwide in Milan, Italy.

Raybow Pharmaceutical Announces Rebranding, Changes Name to Raybow PharmaScience

Raybow has unveiled changes to its’ name, with modifications to the iconic Rainbow Logo as part of a rebranding initiative designed to better reflect the company’s commitment to science.

Raybow PharmaScience announces $15.8 million expansion of U.S. site, tripling capacity and U.S. workforce

Raybow PharmaScience announces $15.8 million expansion of U.S. site, tripling capacity and U.S. workforce